Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort
- PMID: 33555325
- PMCID: PMC8487307
- DOI: 10.1093/rheumatology/keab090
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort
Abstract
Objectives: Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in SLE. We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance.
Methods: The Systemic Lupus International Collaborating Clinics (SLICC) enrolled patients recently diagnosed with SLE (<15 months) from 33 centres across 11 countries from 2000. Clinical, laboratory and therapeutic data were collected. Vitamin D level was defined according to tertiles based on distribution across this cohort, which were set at T1 (10-36 nmol/l), T2 (37-60 nmol/l) and T3 (61-174 nmol/l). MetS was defined according to the 2009 consensus statement from the International Diabetes Federation. Insulin resistance was determined using the HOMA-IR model. Linear and logistic regressions were used to assess the association of variables with vitamin D levels.
Results: Of the 1847 patients, 1163 (63%) had vitamin D measured and 398 (34.2%) subjects were in the lowest 25(OH)D tertile. MetS was present in 286 of 860 (33%) patients whose status could be determined. Patients with lower 25(OH)D were more likely to have MetS and higher HOMA-IR. The MetS components, hypertension, hypertriglyceridemia and decreased high-density lipoprotein (HDL) were all significantly associated with lower 25(OH)D. Increased average glucocorticoid exposure was associated with higher insulin resistance.
Conclusions: MetS and insulin resistance are associated with lower vitamin D in patients with SLE. Further studies could determine whether vitamin D repletion confers better control of these cardiovascular risk factors and improve long-term outcomes in SLE.
Keywords: cardiovascular disease; epidemiology; systemic lupus erythematosus; vitamin D.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures


Similar articles
-
Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010.Nutr J. 2017 Feb 28;16(1):16. doi: 10.1186/s12937-017-0237-6. Nutr J. 2017. PMID: 28241878 Free PMC article.
-
High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.Metab Syndr Relat Disord. 2017 Jun;15(5):213-219. doi: 10.1089/met.2017.0003. Epub 2017 Mar 27. Metab Syndr Relat Disord. 2017. PMID: 28346853
-
Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Ann Rheum Dis. 2013 Aug;72(8):1308-14. doi: 10.1136/annrheumdis-2012-202106. Epub 2012 Sep 3. Ann Rheum Dis. 2013. PMID: 22945501 Free PMC article.
-
Role of Vitamin D in the Metabolic Syndrome.Nutrients. 2021 Mar 3;13(3):830. doi: 10.3390/nu13030830. Nutrients. 2021. PMID: 33802330 Free PMC article. Review.
-
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.Rheumatology (Oxford). 2012 Apr;51(4):644-52. doi: 10.1093/rheumatology/ker212. Epub 2011 Jun 29. Rheumatology (Oxford). 2012. PMID: 21719424 Review.
Cited by
-
Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps-A Rapid Scoping Review.Int J Environ Res Public Health. 2022 Nov 10;19(22):14768. doi: 10.3390/ijerph192214768. Int J Environ Res Public Health. 2022. PMID: 36429489 Free PMC article.
-
Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation.Arthritis Res Ther. 2023 Jan 3;25(1):2. doi: 10.1186/s13075-022-02976-7. Arthritis Res Ther. 2023. PMID: 36597127 Free PMC article. Clinical Trial.
-
Factors associated with 25-hydroxyvitamin D level in Chinese hospitalized patients with systemic lupus erythematosus: a retrospective cohort study.Rheumatol Int. 2024 Oct;44(10):2067-2078. doi: 10.1007/s00296-023-05465-5. Epub 2023 Sep 26. Rheumatol Int. 2024. PMID: 37750894
-
Vitamin D, Gut Microbiota, and Cardiometabolic Diseases-A Possible Three-Way Axis.Int J Mol Sci. 2023 Jan 4;24(2):940. doi: 10.3390/ijms24020940. Int J Mol Sci. 2023. PMID: 36674452 Free PMC article. Review.
-
Confronting the global obesity epidemic: investigating the role and underlying mechanisms of vitamin D in metabolic syndrome management.Front Nutr. 2024 Aug 9;11:1416344. doi: 10.3389/fnut.2024.1416344. eCollection 2024. Front Nutr. 2024. PMID: 39183985 Free PMC article. Review.
References
-
- Kendrick J, Targher G, Smits G. et al.25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009;205:255–60. - PubMed
-
- Dobnig H, Pilz S, Scharnagl H. et al.Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340–9. - PubMed
-
- Urowitz MB, Gladman D, Ibanez D. et al.Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum 2008;59:176–80. - PubMed
-
- Manzi S, Meilahn EN, Rairie JE. et al.Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408–15. - PubMed
-
- Bruce IN, Gladman DD, Urowitz MB.. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin N Am 2000;26:257–78. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Versus Arthritis (Versus Arthritis Research UK Epidemiology Unit Core Support Programme Grant
- National Institute for Health Research (NIHR) Manchester Biomedical Research Centre
- T32 AR007611/AR/NIAMS NIH HHS/United States
- KL2 TR001424/TR/NCATS NIH HHS/United States
- P30 AR072579/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical